CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.

[1]  Adrian Wiestner,et al.  ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.

[2]  G. Guida,et al.  The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. , 2003, Blood.

[3]  Axel Benner,et al.  Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. , 2002, Blood.

[4]  D. Oscier,et al.  CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.

[5]  V. Callea,et al.  Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. , 2002, Haematologica.

[6]  G. Capelli,et al.  Clinical significance of CD38 expression in chronic lymphocytic leukemia. , 2001, Blood.

[7]  K. Do,et al.  CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. , 2001, Blood.

[8]  A. Pettitt,et al.  CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. , 2001, Blood.

[9]  R. Rosenquist,et al.  CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. , 2001, Blood.

[10]  U. Jaeger,et al.  Association of CD38 Antigen Expression with Other Prognostic Parameters in Early Stages of Chronic Lymphocytic Leukemia , 2001, Leukemia & lymphoma.

[11]  A Benner,et al.  Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[12]  T J Hamblin,et al.  Immunoglobulin V genes and CD38 expression in CLL. , 2000, Blood.

[13]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[14]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[15]  E. Thiel,et al.  Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. , 1999, Blood.

[16]  D. Catovsky,et al.  Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). , 1997, American journal of clinical pathology.

[17]  D. Oscier,et al.  Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. , 1997, Blood.

[18]  Robert Vlietinck,et al.  Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases , 1997, British journal of haematology.

[19]  S. Chevret,et al.  Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. , 1996, Blood.

[20]  M. Hallek,et al.  Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. , 1996, Leukemia & lymphoma.

[21]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[22]  D. Catovsky,et al.  The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. , 1994, Leukemia.

[23]  D. Oscier.  Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia. , 1994, Blood reviews.

[24]  T. Cremer,et al.  FISH of Alu-PCR-amplified YAC clones and applications in tumor cytogenetics. , 1994, Methods in molecular biology.

[25]  S. Chevret,et al.  B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL. , 1991, Blood.

[26]  S. Knuutila,et al.  Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. , 1990, The New England journal of medicine.

[27]  D. Catovsky,et al.  Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival , 1989, British journal of haematology.

[28]  P. Giallonardo,et al.  Beta-2-microglobulin is a reliable tumor marker in chronic lymphocytic leukemia. , 1989, Acta haematologica.

[29]  E. Montserrat,et al.  Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages. , 1988, Nouvelle revue francaise d'hematologie.

[30]  H. Kantarjian,et al.  Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. , 1987, Blood.

[31]  W. Gregory,et al.  The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia , 1987, British journal of haematology.

[32]  Ciril Rozman,et al.  Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance , 1986, British journal of haematology.

[33]  E. Montserrat,et al.  Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. , 1984, Blood.

[34]  J. Minowada,et al.  Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  E. Montserrat,et al.  Chronic Lymphocytic Leukaemia: Proposals for a Revised Prognostic Staging System , 1981 .

[36]  Mark J. Thomas,et al.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.

[37]  E. Cronkite,et al.  Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.

[38]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .